Millidrop receives this funding as a laureate of the "Concours d'Innovation" (Innovation Challenge) in the health category with its project "Droplet-Based Integrated Diagnosis from Blood Culture to Antibiogram," that was backed by the Medicen Paris Région competitiveness cluster. MilliDrop's goal is to speed up the microbiological diagnosis process for patients with sepsis.
Worldwide, one person dies every 3-4 seconds from sepsis, causing between 6 and 9 m deaths every year. In industrialised nations, sepsis remains a major cause of death and is responsible for more deaths than HIV, breast cancer and prostate cancer combined.
Sepsis usually occurs following a bacterial infection which spreads to the bloodstream.
The emergence of antibiotic resistance has made it harder to treat. Administering an effective and targeted antibiotic as early as possible is crucial for patient survival and to avoid serious sequelae.
The "Concours d'Innovation" is an excellence-supporting device that operates in the digital technologies field and is financed by the Program of Investments for the Future.
This programme, which is jointly-ran by Bpifrance, ADEME and FranceAgriMer, aims to support innovative projects pursued by SMEs and start-ups.
It also aspires to nurture the emergence of world-class French champions in eight key areas: health; digital; French Fab; security and cybersecurity; transportation and sustainable mobility; renewable energies; storage and energy systems; innovation to enhance the quality of terrestrial, aquatic and marine ecosystems; innovative agriculture.
Eight projects were selected by Bpifrance in the health category for the 2018 Concours d'Innovation 's first wave.
Saluda Medical secures CE certification for EVA Sensing Technology in Europe
Antin to acquire clinical trial equipment provider Emsere
Hyphens Pharma licenses Cerapro skin cream to Louis Widmer for six European markets
Profusa signs French distributor to expand Lumee Oxygen rollout in Europe
Sensiva Health names new chief operating officer
BrioHealth Solutions enrols 100th participant in BrioVAD System trial
Abbott's Amplatzer Piccolo Delivery System receives US FDA clearance and CE Mark
Amphix Bio announces initial closing of USD12.5m seed financing round
Bioretec wins FDA breakthrough status for biodegradable orthopaedic DrillPin
Amferia raises EUR3.5m to advance antimicrobial wound-care platform
BioCryst wins FDA approval for oral HAE prophylaxis in young children
ALR Technologies announces GluCurve Pet CGM relaunch in Canada
Galderma secures EU MDR certification for Sculptra, expanding use to multiple body areas
Clinical Laserthermia Systems applies for CE marking of ClearPoint Prism neuro laser system